Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma, Esophageal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02610764
What this trial is testing

Pilot Sudy: Resectable Esophageal Adenocarcinoma and the Relevance of CTC

Who this might be right for
Esophageal Adenocarcinoma
University Hospital Freiburg 19
Not applicableStudy completedNCT04670445
What this trial is testing

Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer

Who this might be right for
Stage IV MelanomaAdvanced Lung CancerStage IV Non-Small Cell Lung Cancer+19 more
Massachusetts General Hospital 199
Not applicableLooking for participantsNCT06558786
What this trial is testing

Registry for Esophageal and Gastroesophageal Junction Cancer

Who this might be right for
Gastroesophageal-junction CancerEsophageal Cancer
Memorial Sloan Kettering Cancer Center 50
Large-scale testing (Phase 3)Ended earlyNCT01697072
What this trial is testing

First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma

Who this might be right for
Gastric Cancer
Amgen 609
Not applicableLooking for participantsNCT00574327
What this trial is testing

Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the Creation of a Barrett's Registry

Who this might be right for
Barrett's EsophagusGastroesophageal Reflux DiseaseEsophageal Adenocarcinoma
Midwest Biomedical Research 3,000
Not applicableNot Yet RecruitingNCT07343869
What this trial is testing

Multicenter Prospective Cohort on Esophageal Endoscopic Submucosal Dissection

Who this might be right for
Superficial Esophageal CancerOesophageal AdenocarcinomaOesophageal Squamous Cell Carcinoma+1 more
Société Française d'Endoscopie Digestive 750
Not applicableActive Not RecruitingNCT04878783
What this trial is testing

Radiomics and Molecular Expression Predictive Model for Esophago-Gastric Junction and Gastric Cancer TRG

Who this might be right for
Gastric CancerAdenocarcinoma of the Stomach
University of Roma La Sapienza 138
Early research (Phase 1)Looking for participantsNCT07359443
What this trial is testing

Combination of Chemotherapy and Adaptive MR-Guided Radiotherapy to Improve Outcomes in Patients With Esophageal Adenocarcinoma

Who this might be right for
Esophageal AdenocarcinomaEsophageal Adenocarcinoma (EAC)Adenocarcinoma - Gastroesophageal Junction (GEJ)
UMC Utrecht 39
Early research (Phase 1)Looking for participantsNCT06657144
What this trial is testing

CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

Who this might be right for
Metastatic Solid TumorAdvanced Solid Tumor
Coherus Oncology, Inc. 154
Testing effectiveness (Phase 2)Study completedNCT03141034
What this trial is testing

Ramucirumab Plus Irinotecan for Previously Treated Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma

Who this might be right for
Gastric AdenocarcinomaGastro-esophageal Junction Adenocarcinoma
Washington University School of Medicine 40
Testing effectiveness (Phase 2)Study completedNCT01498289
What this trial is testing

S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionEsophageal CancerGastric Cancer
SWOG Cancer Research Network 213
Early research (Phase 1)Active Not RecruitingNCT05462717
What this trial is testing

Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma+1 more
Revolution Medicines, Inc. 222
Not applicableUnknownNCT02607826
What this trial is testing

Short-term Starvation vs. Normal Diet Before Chemotherapy of Solid Tumors

Who this might be right for
CholangiocarcinomaPancreatic Ductal AdenocarcinomaColorectal Cancer+3 more
University Hospital Tuebingen 298
Not applicableStudy completedNCT03015389
What this trial is testing

Wide Area Transepithelial Sample Esophageal Biopsy Combined With Computer Assisted 3-Dimensional Tissue Analysis (WATS3D) For the Detection of High Grade Esophageal Dysplasia and Adenocarcinoma

Who this might be right for
Barrett EsophagusEsophageal DysplasiaEsophageal Adenocarcinoma
CDx Diagnostics 170
Testing effectiveness (Phase 2)Study completedNCT00054873
What this trial is testing

Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer

Who this might be right for
Esophageal NeoplasmsStomach NeoplasmsAdenocarcinoma
Chiron Corporation
Not applicableStudy completedNCT00900094
What this trial is testing

UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer

Who this might be right for
Breast CancerColorectal CancerEsophageal Cancer+4 more
University of Michigan Rogel Cancer Center 200
Testing effectiveness (Phase 2)Study completedNCT00220103
What this trial is testing

Pre-operative Epirubicin, Cisplatin, and Capecitabine in Patients With Newly Diagnosed Localised Oesophageal Adenocarcinoma

Who this might be right for
Adenocarcinoma of Oesophagus
Royal Marsden NHS Foundation Trust 80
Not applicableLooking for participantsNCT07660627
What this trial is testing

Determining Minimal Residual Disease Using ctDNA Deep Sequencing

Who this might be right for
Esophageal AdenocarcinomaGastric CancerPancreatic Cancer
Masaryk Memorial Cancer Institute 34
Testing effectiveness (Phase 2)Ended earlyNCT02016534
What this trial is testing

Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors

Who this might be right for
Stomach Neoplasms
Amgen 60
Testing effectiveness (Phase 2)UnknownNCT03013712
What this trial is testing

A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer

Who this might be right for
Colon CancerEsophageal CarcinomaPancreatic Cancer+3 more
First Affiliated Hospital of Chengdu Medical College 60
Next Page